Home > Healthcare & Medical Devices > Biliary Stents Market

Biliary Stents Market Size By Type (Metal Stents, Polymer Stents), By Application (Bilio-pancreatic Leakages, Pancreatic Cancer, Benign Biliary Strictures, Gallstones), By End-use (Hospitals, Specialty Clinics, Ambulatory Surgical Centers), COVID-19 Impact Analysis, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2023 – 2032

  • Report ID: GMI4034
  • Published Date: Dec 2022
  • Report Format: PDF

Industry Statistics

Biliary Stents Market size surpassed USD 394.5 million in 2022 and is anticipated to record more than 5.5% CAGR between 2023-2032. Technological advancements in detection and treatment of gastrointestinal diseases will augment industry share.
 

Get more details on this report - Request Free Sample PDF
 

Rising number of patients suffering from gallstones and the growing prevalence of pancreatic and bile duct cancers will increase the use of biliary stents across the world. For instance, according to the American Cancer Society, close to 8,000 people in the U.S. are diagnosed with bile duct cancer (cholangiocarcinoma) annually. Furthermore, the rising adoption of endoscopic retrograde cholangiopancreatography (ERCP) and percutaneous transhepatic cholangiography (PTC) procedures will also boost the demand for biliary stents significantly, thereby augmenting the market expansion.
 

Technological advancements in the detection and treatment of gastrointestinal diseases, including bile duct obstruction, are leading to several advantages, such as lesser chances of infection, shorter hospital stays, and quicker recovery. Other technological innovations, such as self-expandable metallic stents and bioresorbable stents, enable larger lumen that allows improved patency rate and decreased biofilm formation. Enhanced accuracy levels of ERCP and PTC tests and the burgeoning adoption of minimally invasive surgeries through effective diagnosis procedures are also promoting the usage of biliary stents.
 

However, various risks and complications associated with bile duct stents might hinder the biliary stents market growth. Risk factors such as tumor ingrowth can cause blockage in stents, leading to the buildup of microbial colonies or biofilm formation due to the accumulation of obstructing material. Another severe complication of biliary stenting is the risk of a hole forming in the duodenum during or after the stent placement, which can cause bleeding or infection and create other major problems. These factors may also impede market progress to some extent.
 

Cost-effectiveness and easy removal will fuel demand for polymer stents

Get more details on this report - Request Free Sample PDF
 

Biliary stents market size from polymer stent products is expected to register more than 5% CAGR through 2032. The robust product adoption is attributed to the usage of hydrophobic materials that are relatively inexpensive compared to their metal counterparts. Polymer stents placed in the bile duct also safeguard the protective barrier function of the sphincter of Oddi, through the prevention of bacteria formation in the biliary tract and the stent. Various other advantages of polymer stents, including easy removal, cost saving, and minimal hospital stay are also expected to boost product consumption.
 

Biliary stents to emerge as preferred treatment solutions for benign biliary structures

Biliary stents market share from benign biliary structure applications is projected to be valued at more than USD 29 million by 2032. The strong need for these stents is attributed to the increasing prevalence of cancer, chronic illness, and liver disease. Also, the incidence rate of bile duct injury is approximately 0.2-0.3%, and close to 0.4-0.6% after an open cholecystectomy procedure. These aspects are anticipated to positively impact the industry trends.
 

Rising preference for minimally invasive surgeries will boost product use in specialty clinics

Get more details on this report - Request Free Sample PDF
 

Biliary stents market revenue from specialty clinics end-use segment is estimated to cross USD 26.5 million by 2032. The overall network of these clinics is growing at a notable rate across developed and developing nations, presenting significant treatment options to patients suffering from chronic ailments. Also, more patients, especially among the elderly population, are opting for minimally invasive surgical procedures as they cause minimal scarring and enhance patient outcomes. This will have a significant impact on the demand for endoscopic biliary stent surgeries, thereby bolstering product adoption in facilities such as specialty clinics.
 

High healthcare expenditure to improve Latin America biliary stents industry forecasts

Get more details on this report - Request Free Sample PDF
 

Latin America biliary stents market size is projected to depict more than 4.5% CAGR through 2032. The healthcare sector in the region is witnessing substantial growth due to heavy investments by governments in a wide range of innovative medical technologies. Several hospitals and ambulatory surgical centers in the region are being equipped with advanced diagnostic technologies, which will play a vital role in the development of the biliary stents industry in Latin America.
 

Certifications from regulatory authorities to help players increase their industry footprint

Boston Scientific, Cook Group, ENDO-FLEX GmbH, Olympus Corporation, B Braun Melsungen, CONMED Corporation, M.I Tech, C.R. Bard (Becton, Dickinson & Company), Medtronic plc, Cardinal Health, and Merit Medical System, are a few of the prominent companies operating in the biliary stents market. These enterprises are seeking the approval of reputed medical bodies to promote their products and enhance their market presence.
 

Effect of COVID-19 pandemic on biliary stents market progress

COVID-19 pandemic had a negative impact on biliary stents industry expansion as the outbreak disrupted the healthcare system across the globe, causing delays in surgeries, treatment, and diagnosis of non-emergent conditions. Many local and national regulatory bodies also enforced lockdowns, restricting the movement of people and goods.
 

These lockdowns had a severe impact on supply chains across the globe, resulting in the delayed and limited supply of equipment such as biliary stents to end users. Also, most routine gastrointestinal endoscopic surgeries were delayed, as only life-threatening emergencies were treated. However, by the end of 2020, as the restrictions were eased and lockdowns were lifted, a significant recovery was observed in the overall volume of ERCP procedures, which surged the demand for bile duct stents.
 

The biliary stents market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments:

By Type

  • Metal Stents
  • Polymer Stents

By Application

  • Bilio-pancreatic Leakages
  • Pancreatic Cancer
  • Benign Biliary Structures
  • Gallstones
  • Others

By End-use

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centres
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Russia
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia

 

Authors: Rupali Swain, Subodh Kharad

Frequently Asked Questions (FAQ) :

Global market size for biliary stents revenue surpassed USD 394.5 million in 2022 and is anticipated to record more than 5.5% CAGR over 2023-2032, due to the rising incidence of bile duct & liver cancers and gastrointestinal diseases.
Polymer biliary stents industry size is expected to register more than 5% CAGR through 2032, due to the widespread demand for hydrophobic materials that are more affordable as compared to their metal counterparts.
Latin America biliary stents market size is projected to depict more than 4.5% CAGR through 2032, given the rapid expansion of the healthcare sector and investments by governments in a wide range of innovative medical technologies.
Boston Scientific, Cook Group, ENDO-FLEX GmbH, Olympus Corporation, B Braun Melsungen, CONMED Corporation, M.I Tech, C.R. Bard (Becton, Dickinson & Company), Medtronic plc, Cardinal Health, and Merit Medical System, are a few of the prominent companies operating in biliary stents business.

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 11
  • Tables & Figures: 181
  • Countries covered: 17
  • Pages: 139
  • Upcoming Report: Details can be customized to meet your information and data needs. Feel free to share your detailed research requirements via this form.

Get a report that explains COVID-19 impact on this market

 Request Free Sample

Budget constraints? Get in touch with us for special pricing

Request Discount